Venetoclax-Ibrutinib Combinations as First-Line Therapy in Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials with GRADE Approach
Objective: Chronic lymphocytic leukemia (CLL) treatment has shifted from chemoimmunotherapy to targeted agents. Venetoclax and ibrutinib, which act through complementary mechanisms, have shown promise in achieving deep remissions. Their combination may enhance efficacy, but pooled evidence from rand...
Zapisane w:
| Główni autorzy: | , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Erzincan Binali Yıldırım University School of Medicine
2026-01-01
|
| Seria: | Archives of Basic and Clinical Research |
| Hasła przedmiotowe: | |
| Dostęp online: | https://abcresearch.net/articles/venetoclax-ibrutinib-combinations-as-first-line-therapy-in-chronic-lymphocytic-leukemia-a-meta-analysis-of-randomized-controlled-trials-with-grade-approach/doi/ABCR.2025.25386 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|